Balyasny Asset Management
DARE icon

Balyasny Asset Management’s Dare Bioscience DARE Stock Holding History

Balyasny Asset Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-103
Closed -$45K – 1272
2015
Q3 		$45K Sell
103
-38
-27% -$19.1K ﹤0.01% 1099
2015
Q2 		$78K Buy
+141
New +$96.8K ﹤0.01% 1086

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Balyasny Asset Management's DARE Position: Q4 2015 in Review

Balyasny Asset Management sold out of Dare Bioscience (DARE) in Q4 2015, closing a stake of 103 shares — an estimated $45K sold.

Balyasny Asset Management first reported a position in DARE in Q2 2015 and held it in 2 quarters. The position peaked at $78K in Q2 2015. 37 funds tracked by Wall St. Rank hold DARE as of Q4 2015.

  • Balyasny Asset Management reported no remaining Dare Bioscience position as of Q4 2015 after selling out during the quarter.
  • Balyasny Asset Management sold 103 Dare Bioscience shares in Q4 2015, an estimated $45K.
  • Balyasny Asset Management first reported a position in Dare Bioscience in Q2 2015 and held it in 2 quarters.
  • Balyasny Asset Management's Dare Bioscience position peaked at $78K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2015.

Based on Balyasny Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.